Trial

NCT05532046

A Study to Learn How Safe Study Drug BAY2413555 is, How it Affects the Body, and How it Moves Into, Through, and Out of the Body Over 4 Weeks of Use in Participants With Heart Failure and Implanted Cardiac Defibrillator or Cardiac Resynchronization Devices (ICD/CRT)
Phase ITERMINATEDSAFETYConfidence: MEDIUM
Sponsor
Bayer
Collaborators
Condition
Chronic Heart Failure
Intervention
BAY2413555 Dose 1
Why stopped
Due to new preclinical findings in a chronic toxicology study.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-12